With extensive experience in technology and healthcare investments, the fund manager has successfully completed over 50 deals across North America and Europe. Their strategic focus on operator-first investments has led to notable exits, including a successful acquisition in the biotech sector. Emphasizing a data-driven approach, they build portfolios that align with emerging market trends and innovative technologies. Their hands-on style supports early-stage companies, fostering growth and maximizing value creation.